Cardiac Metabolism as a Target for the Treatment of Heart Failure
- 24 August 2004
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 110 (8) , 894-896
- https://doi.org/10.1161/01.cir.0000139340.88769.d5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Recombinant Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake and Improves Left Ventricular Performance in Conscious Dogs With Pacing-Induced Dilated CardiomyopathyCirculation, 2004
- Learning about Cardiac Calcium Signaling from Genetic EngineeringAnnals of the New York Academy of Sciences, 2004
- Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful ReperfusionCirculation, 2004
- Load-induced changes in vivo alter substrate fluxes and insulin responsiveness of rat heart in vitroMetabolism, 2001
- Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group.British Journal of Clinical Pharmacology, 1994
- Energy metabolism of the heart: From basic concepts to clinical applications applicationsCurrent Problems in Cardiology, 1994
- Improved Cardiac Function With Glucose-Insulin-Potassium After Aortocoronary Bypass GraftingThe Annals of Thoracic Surgery, 1989
- Effects of experimental heart failure on the capacity of glucagon to augment myocardial contractility and activate adenyl cyclaseJournal of Clinical Investigation, 1970
- Effect of glucagon on rat heart adenyl cyclaseBiochemical Pharmacology, 1969
- THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUSPublished by Elsevier ,1963